Senti Biosciences Holdings, Inc. (SNTI) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$43.44M | -4.9% |
| 2024 | -$41.40M | +21.0% |
| 2023 | -$52.40M | -50.1% |
| 2022 | -$34.90M | -0.8% |
| 2021 | -$34.63M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$43.44M | -4.9% |
| 2024 | -$41.40M | +21.0% |
| 2023 | -$52.40M | -50.1% |
| 2022 | -$34.90M | -0.8% |
| 2021 | -$34.63M | — |